Side Effects of abemaciclib: A Synthesis of Findings from 15 Studies
- Home
- Side Effects of abemaciclib
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of abemaciclib: A Synthesis of Findings from 15 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Abemaciclib is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor used to treat metastatic breast cancer that is hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) 4 , 2 . When used in combination with hormone therapy, abemaciclib is expected to suppress tumor cell growth and extend survival time. 6 , 8 . However, some side effects have been reported with abemaciclib. 15 , 9 , 11 .
Reasons for Side Effects
Abemaciclib inhibits CDK4/6 to suppress the growth of cancer cells. CDK4/6 are important proteins involved in cell cycle progression. Inhibition of CDK4/6 affects the growth of normal cells as well as cancer cells. Therefore, the side effects of abemaciclib are thought to be caused by inhibition of the cell cycle. 2
Common Side Effects
Diarrhea
Diarrhea is the most commonly reported side effect of abemaciclib. 15 . Diarrhea may occur a few days to a few weeks after starting abemaciclib. The severity of diarrhea can vary from mild to severe. 15 . Diarrhea may improve when abemaciclib is discontinued. Taking antidiarrheal medications such as loperamide can alleviate the symptoms of diarrhea. 15 .
Fatigue
Fatigue has also been reported as a side effect of abemaciclib. 15 . Fatigue may occur a few days to a few weeks after starting abemaciclib. Fatigue may improve when abemaciclib is discontinued. Getting enough rest can help reduce fatigue.
Liver dysfunction
Liver dysfunction has also been reported as a side effect of abemaciclib. 9 . Liver dysfunction may occur a few days to a few weeks after starting abemaciclib. Liver dysfunction may improve when abemaciclib is discontinued. Liver dysfunction is caused by inflammation and damage to liver cells. Symptoms of liver dysfunction include jaundice, abdominal pain, and loss of appetite. Liver dysfunction can be detected by blood tests.
Cardiac Dysfunction
Cardiac dysfunction has also been reported as a side effect of abemaciclib. 11 . Cardiac dysfunction may occur a few days to a few weeks after starting abemaciclib. Cardiac dysfunction may improve when abemaciclib is discontinued. Cardiac dysfunction is caused by a decrease in the contractility and ejection fraction of the heart. Symptoms of cardiac dysfunction include shortness of breath, palpitations, and edema. Cardiac dysfunction can be detected by echocardiogram.
Skin Hyperpigmentation
Skin hyperpigmentation has also been reported as a side effect of abemaciclib. 12 . Skin hyperpigmentation may occur a few days to a few weeks after starting abemaciclib. Skin hyperpigmentation may improve when abemaciclib is discontinued. Skin hyperpigmentation is caused by excessive melanin production. Skin hyperpigmentation mainly appears on the face, neck, chest, and hands. Skin hyperpigmentation can be prevented by avoiding exposure to ultraviolet rays.
Hypertension
Hypertension has also been reported as a side effect of abemaciclib. 5 . Hypertension may occur a few days to a few weeks after starting abemaciclib. Hypertension may improve when abemaciclib is discontinued. Hypertension puts a strain on the heart and increases the risk of cardiovascular disease. Hypertension can be treated with lifestyle changes and antihypertensive medications.
Countermeasures for Side Effects
Countermeasures for Diarrhea
Diarrhea caused by abemaciclib can be alleviated by taking antidiarrheal medications such as loperamide. 15 . Dietary therapy is also effective. Avoid fatty foods and stimulants, and eat easily digestible foods. It is also important to stay hydrated. If diarrhea is severe, consult a doctor.
Countermeasures for Fatigue
Fatigue caused by abemaciclib can be reduced by getting enough rest. Make sure you get enough sleep. Light exercise and stretching are also effective. If fatigue is severe, consult a doctor.
Countermeasures for Liver Dysfunction
Liver dysfunction caused by abemaciclib can be monitored by regular blood tests. If liver function worsens, you may need to reduce the dose of abemaciclib or stop taking it. Follow your doctor's instructions and undergo regular checkups.
Countermeasures for Cardiac Dysfunction
Cardiac dysfunction caused by abemaciclib can be monitored by regular echocardiograms. If cardiac function worsens, you may need to reduce the dose of abemaciclib or stop taking it. Follow your doctor's instructions and undergo regular checkups.
Countermeasures for Skin Hyperpigmentation
Skin hyperpigmentation caused by abemaciclib can be prevented by avoiding exposure to ultraviolet rays. Apply sunscreen, wear a hat and use an umbrella. If hyperpigmentation has already occurred, it can be improved by using whitening creams or undergoing laser treatment. Consult a doctor if you are concerned about skin changes.
Countermeasures for Hypertension
Hypertension caused by abemaciclib can be treated with lifestyle changes and antihypertensive medications. Reduce your salt intake and eat plenty of fruits and vegetables. Regular exercise is also effective. Quitting smoking is also important. If you are concerned about hypertension, consult a doctor.
Comparison between Studies
Commonalities between Studies
Abemaciclib is a CDK4/6 inhibitor used to treat metastatic breast cancer and is expected to be effective when combined with hormone therapy.
Differences between Studies
There are differences in the types and severity of side effects reported in different studies on abemaciclib. For example, some studies report diarrhea as the most common side effect, while others report liver dysfunction and cardiac dysfunction. In addition, some studies report an association between abemaciclib side effects and hypertension, while others do not. Differences in research results may be due to differences in the characteristics of the study subjects and the study design. Further research is needed to better understand the side effects of abemaciclib.
Caution Regarding Application to Real Life
Abemaciclib is an effective drug for treating metastatic breast cancer, but it is important to understand the risk of side effects. When taking abemaciclib, it is important to discuss your health condition and any other medications you are taking with your doctor. It is also important to receive information from your doctor about the side effects of abemaciclib, undergo regular checkups, and manage your health condition.
Limitations of Current Research
Research on the side effects of abemaciclib is still insufficient. In particular, there is still much that is unknown about long-term and rare side effects. In addition, differences in research results may be due to differences in the characteristics of the study subjects and the study design, and further research is needed.
Future Research Directions
Research on the side effects of abemaciclib needs to be further advanced. In particular, elucidating long-term and rare side effects, developing methods for preventing and treating side effects, elucidating individual differences in side effects, and evaluating the risks and benefits of side effects are important research topics.
Conclusion
Abemaciclib is an effective drug for treating metastatic breast cancer, but it also carries the risk of side effects. When taking abemaciclib, it is important to consult with your doctor and manage your health condition. Future research is expected to provide a deeper understanding of the safety and effectiveness of abemaciclib.
Benefit Keywords
Risk Keywords
Article Type
Author: MarksKatherine R, LileJoshua A, StoopsWilliam W, RushCraig R
Language : English
Author: PavlovicDragica, NiciforovicDanijela, PapicDragana, MilojevicKatarina, MarkovicMarina
Language : English
Author: TerasawaRisa, TakashimaYuko, HirataAoko, KimuraKosei, MoritaShinsho, HayashiMichihiro
Language : Japanese
Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.
Author: Collada SánchezVictoria Lucia, Álvarez CriadoJavier, Martinez MartinVirginia, Zamora AuñonPilar, Espinosa ArranzEnrique, Mayor IbargurenAnder, Nacher JimenezInmaculada, Herrero AmbrosioAlicia
Language : English
Author: ShuYamin, WangLei, DingYiling, ZhangQilin
Language : English
Author: DegenhardtTom, FaschingPeter A, LüftnerDiana, MüllerVolkmar, ThomssenChristoph, SchemChristian, WitzelIsabell, DeckerThomas, TeschHans, KümmelSherko, UleerChristoph, WuerstleinRachel, HoffmannOliver, WarmMathias, MarschnerNorbert, SchinkötheTimo, KatesRonald E, SchumacherJohannes, OtrembaBurkhard, ZaissMatthias, HarbeckNadia, SchmidtMarcus,
Language : English
Author: MüllerCarolin, KiverVerena, SolomayerErich-Franz, WagenpfeilGudrun, NeebCaroline, BlohmerJens-Uwe, AbramianAlina Valik, MaassNicolai, SchützFlorian, Kolberg-LiedtkeCornelia, RalserDamian Johannes, RambowAnna-Christina
Language : English
Author: AbdelmalakMary, SinghRajanbir, AnwerMohammed, IvanchenkoPavel, RandhawaAmritdeep, AhmedMyra, AshtonAnthony W, DuYanming, JiaoXuanmao, PestellRichard
Language : English
Author: HuyutZübeyir, UçarBünyamin, AltındağFikret, YıldızhanKenan, HuyutMehmet Tahir
Language : English
Author: NakatsukasaHitomi, TakahashiMasaya, TakahashiKatsuyuki, TakashimaTsutomu, AsanoYuka, MorisakiTamami, KashiwagiShinichiro, NodaSatoru, NakamuraYasutaka
Language : English
Author: HuyutZübeyir, UçarBünyamin, YıldızhanKenan, AltındağFikret
Language : English
A Likely Case of Abemaciclib-Induced Hyperpigmentation in a Patient With Metastatic Breast Cancer.
Author: Salusti-SimpsonMichela, PorterHannah, MorleyKeith
Language : English
Author: CiciniMaria Paola, FerrettiGianluigi, MoraceNicola, NisticòCecilia, CognettiFrancesco, RulliFrancesco
Language : English
Author: MataDanilo Giffoni de Mello Morais, Amir CarmonaCarlos, EisenAndrea, TrudeauMaureen
Language : English
Author: GebbiaVittorio
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.